Company: NCEL
Filing Date: 2025-11-06
Form Type: POS AM
Source: 0001213900-25-106799
Chunk: 82

Company: NewcelX Ltd.
Filing Date: 2025-11-06
Form: POS AM
Chunk 82
---
 any index and is unsecured. The loan shall remain in effect for a period of 1 year, which shall automatically be renewed for consecutive 12 -monthperiods, unless the parties agree to an earlier repayment in writing, at least 30 days prior to the end of the applicable term. Subject to the approval of the Company’s general meeting of shareholders, which was obtained on June 10, 2025, the loan shall be converted into Company ordinary shares, at the earlier of (i) a date close to the closing date of the Company’s merger transaction with NLS, if and when completed, at the market price as that time (calculated as the average share price of the 14 trading days before the conversion date) or (ii) alternatively, upon an event under which the Company completed a capital raising close to the completion date of the merger transaction or any other capital raising, according to the share price and other terms of the aforementioned capital raising. During the reporting period, the Company recorded in the capital reserve from transactions with controlling shareholders in a total amount of $53 thousand, before deducting an amount of $12 thousand due to a tax benefit. Annex B-11 KADIMASTEM LTD.
NOTES TO INTERIM FINANCIAL STATEMENTS

H.As noted in Note 3F above, on June 30, 2025, the Company, together with NLS, announced the completion of the remaining fundraising through a private placement transaction that amounted to $1 million. The share price of the fundraising transaction was determined at $1.65, which reflects a 10% premium above NLS common share price at the signing date of the fundraising agreement (i.e., March 28, 2025). The primary purpose of the fundraising is to provide financing for the merger transaction and the subsequent period, to support working capital needs, and for other general corporate purposes. NOTE 4 — GENERAL AND ADMINISTRATIVE EXPENSES

|                                           |     | Six months ended 
          June 30 
             2025 |     | 2024 |   |     |   Year ended 
 December 31, 
         2024 |   |
|:------------------------------------------|:----|-----------------:|:----|-----:|:--|:----|-------------:|:--|
|                                           |     |        Unaudited |     |      |   |     |      Audited |   |
|                                           |     | USD in thousands |     |      |   |